2196.HK 600196.SHG
Bayzed does healthcare

Shanghai Fosun Pharmaceutical (Group) Co. Ltd. (2196.HK; 600196.SH) said on Monday that Shanghai Fosun High Technology, a subsidiary of Fosun International (0656.HK), has pledged 198 million shares of the Shanghai-listed A-shares it holds in Fosun Pharma to banking giant ICBC. The pledged shares account for 7.4% of Fosun Pharma’s total, and Fosun High Tech will use proceeds raised through the share pledge to repay debts.

Together with previously pledged shares, Fosun has pledged a total of nearly 720 million of Fosun Pharma’s A-shares, accounting for 26.65% of its total.

Fosun Pharma said agreements involving 433 million of its pledged shares will expire within one year, accounting for approximately 16.2% of the company’s total shares, involving an amount of 4.36 billion yuan.

By Lau Chi Hang

To subscribe to Bamboo Works weekly free newsletter, click  here

Recent Articles

Illustration of Hong Kong as a ipo pipeline and crypto lab for China

Hong Kong: China’s IPO pipeline and crypto lab

Companies raised $13.6 billion through Hong Kong IPOs in the first half of the year, giving the city the global fundraising title for that period. What's behind the sudden boom? And a growing number of Chinese companies are experimenting with cryptocurrencies in Hong Kong, even as such currencies are banned on the Mainland. What's driving such different approaches on the Mainland and in Hong Kong?